Vincenzo Atella
Vincenzo Atella
Professor of Economics, Università Roma Tor Vergata
Adresse e-mail validée de
Citée par
Citée par
Stochastic frontier analysis using Stata
F Belotti, S Daidone, G Ilardi, V Atella
The Stata Journal 13 (4), 719-758, 2013
Trends in age‐related disease burden and healthcare utilization
V Atella, A Piano Mortari, J Kopinska, F Belotti, F Lapi, C Cricelli, ...
Aging cell 18 (1), e12861, 2019
Mediterraneo del Nord: un'altra idea del Mezzogiorno
N Rossi, C Amadei, V Atella
Laterza, 2005
The efficiency frontier approach to economic evaluation of health‐care interventions
JJ Caro, E Nord, U Siebert, A McGuire, M McGregor, D Henry, ...
Health economics 19 (10), 1117-1127, 2010
Are employers discriminating with respect to weight?: European Evidence using Quantile Regression
V Atella, N Pace, D Vuri
Economics & Human Biology 6 (3), 305-329, 2008
Determinants of access to physician services in Italy: a latent class seemingly unrelated probit approach
V Atella, F Brindisi, P Deb, FC Rosati
Health economics 13 (7), 657-668, 2004
Determinants of access to physician services in Italy: a latent class seemingly unrelated probit approach
V Atella, F Brindisi, P Deb, FC Rosati
Health economics 13 (7), 657-668, 2004
Household portfolio choices, health status and health care systems: A cross-country analysis based on SHARE
V Atella, M Brunetti, N Maestas
Journal of banking & finance 36 (5), 1320-1335, 2012
Prescription drug utilization following patient co‐payment changes in Australia
P McManus, N Donnelly, D Henry, W Hall, J Primrose, J Lindner
Pharmacoepidemiology and Drug Safety 5 (6), 385-392, 1996
Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: a cost‐of‐illness analysis
JM Schattenberg, JV Lazarus, PN Newsome, L Serfaty, A Aghemo, ...
Liver International 41 (6), 1227-1242, 2021
The cost of prescription medicines to patients
PR Noyce, C Huttin, V Atella, G Brenner, FM Haaijer-Ruskamp, ...
Health Policy 52 (2), 129-145, 2000
Drug compliance, co‐payment and health outcomes: evidence from a panel of Italian patients
V Atella, F Peracchi, D Depalo, C Rossetti
Health economics 15 (9), 875-892, 2006
Are primary care physicians, public and private sector specialists substitutes or complements? Evidence from a simultaneous equations model for count data
V Atella, P Deb
Journal of health economics 27 (3), 770-785, 2008
Investment and exchange rate uncertainty
V Atella, GE Atzeni, PL Belvisi
Journal of Policy Modeling 25 (8), 811-824, 2003
Drug cost containment policies in Italy: are they really effective in the long-run?: The case of minimum reference price
V Atella
Health policy 50 (3), 197-218, 2000
Affordability of medicines and patients’ cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK
V Atella, E Schafheutle, P Noyce, K Hassell
Applied health economics and health policy 4, 23-35, 2005
Do R&D expenditures really matter for TFP?
V Atella, B Quintieri
Applied Economics 33 (11), 1385-1389, 2001
Body weight, eating patterns, and physical activity: The role of education
V Atella, J Kopinska
Demography 51 (4), 1225-1249, 2014
Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK–Italy comparison
K Hassell, V Atella, EI Schafheutle, MC Weiss, PR Noyce
The European Journal of Public Health 13 (1), 18-23, 2003
Measuring spatial effects in the presence of institutional constraints: The case of Italian Local Health Authority expenditure
V Atella, F Belotti, D Depalo, AP Mortari
Regional Science and Urban Economics 49, 232-241, 2014
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20